A pharmacy that ships a Unified Program Integrity Contractor (UPIC) audit notice often assumes every Medicare claim the pharmacy filed is now on the table. UPICs review Medicare Part A, Part B, durable medical equipment, home health and hospice claims, and Medicaid claims. Part D prescription drug claims run through a separate CMS track, and pharmacies that treat the two audits as one lose time drafting the wrong response while the real Part D exposure builds in the background.
Two Separate Audit Tracks Under Medicare
CMS assigns Medicare and Medicaid claim review to five geographic UPIC jurisdictions, and their mandate covers Parts A and B, DME, home health and hospice, and Medicaid, including the Medi-Medi data-match program that cross-references Medicare and Medicaid billing for the same provider. Part C and Part D program integrity sit with a different office entirely: CMS's Center for Program Integrity, Division of Prescription Drug Audits, working through the Medicare Drug Integrity Contractor. A pharmacy can be a UPIC target on its Part B and Medicaid claims and, at the same time, sit under a completely separate Part D review that never touches the UPIC file.
How Prescriber Pattern Analysis Flags a Pharmacy
Both tracks run on the same underlying technique: compare a pharmacy or prescriber against its peers and flag what does not match. On the Part D side, that means dispensing volume that outpaces similarly sized pharmacies, a prescriber whose patient panel is disproportionately concentrated at one pharmacy, days-supply patterns that do not track the drug's labeled use, and high-risk drug categories, opioids, compounded formulations, and high-cost specialty drugs, that draw review before lower-cost maintenance medications do. A pharmacy that fills for a small number of high-volume prescribers is a common starting point for this kind of analysis, on either track.
Where UPIC Findings and Part D Exposure Overlap
The Medi-Medi data match is the bridge. Once a UPIC flags a prescriber or pharmacy on Part B or Medicaid claims, the same NPI's billing pattern is visible to reviewers working the Part D side, and a recoupment finding on one program's claims routinely becomes the reason a plan sponsor or its PBM opens its own Part D audit of the same pharmacy. The reverse happens too: a PBM audit that documents a pattern of unsupported fills can be referred into the UPIC's Part B and Medicaid review of the same prescriber relationship. Our guide to how a UPIC audit becomes a law enforcement referral covers what happens once that pattern crosses from an audit finding into an investigative one.
A UPIC audit and a Part D audit can run on the same prescriber and pharmacy at the same time without either reviewer ever citing the other's file.
Documentation That Crosses Both Tracks
The records a UPIC requests to verify a Part B or Medicaid fill, the prescription itself, the signature log confirming the beneficiary received the drug, and any prior authorization on file, are close cousins of what a Part D reviewer or PBM asks for on the same prescriber's claims. Our walkthrough of responding to a UPIC records request and our guide to UPIC prepayment review as an exit strategy both apply directly to a pharmacy managing a UPIC file and a Part D audit at once, since a documentation gap addressed once should not have to be rebuilt twice. When either track escalates, a target letter naming the pharmacy or a prescriber as a subject is the clearest signal that the matter has moved from audit to investigation.
Why Early Legal Counsel Is Critical
It is critical that pharmacies and physicians promptly retain experienced healthcare defense counsel upon receiving a UPIC audit notice, a Part D audit request, a records request, or any other government inquiry. Early legal intervention can protect the pharmacy's rights, ensure the response to one track does not create exposure on the other, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with reviewers on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of both matters and expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies and physicians facing UPIC audits, Part D program integrity review, and the PBM audits that so often follow the same prescriber or pharmacy pattern. Our bench includes a former federal prosecutor and attorneys with direct experience on the payor and PBM side of these reviews. If your pharmacy is managing a UPIC audit, a Part D claim review, or both at once, contact us today for a free consultation.
